By Ben Glickman Shares of Astria Therapeutics rose after the company secured a licensing deal for a potential treatment of atopic dermatitis. The stock was…
Markets – MarketWatch
Astria Therapeutics Shares Rise 8.9% After Licensing Deal for Dermatitis Treatment Markets – MarketWatch
